Newsbenzinga
LENZ Therapeutics Announces Reorganization To Cut 2027 Operating Expenses By Over 50% To About $70M-$75M, Excluding Stock-Based Compensation
· Published
Article summary
Please check the source for details.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…